/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749876684&Signature=KS8ODHxnYc3xzBMWeJes2u010~~jg-fOQUs~3OLBf0WtkmZdZ9Ka4A7XamOlmsPTSFKZitESpHOLnC8IXHzp9LVMkCtkHz~yKhN0uVOTEXQJDm5p-1UVgN0aeg7wdRk3VqZeW4H4iDVXw12lMULVg7IosfgCf~BSy9rfE7RB0jgD-92Ne3cesLRD~G~a7vW44fhUYGlegd-Yvx8WMf7Q-2cdoxZL7vUAk4GMkcDR52qvCH2SOY1xaLGQsuvDKuWWlwL1m7z4eeH~ljEgQTz6Z5ONI5NNiSNEKi7x2nM8jwiQmEHmqYfYs8jlq35LSZPCE4J3cxJidtCx8dsapbZn6w__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO | |
|
Herantis Pharma Oyj | Finland | HRTIS |